Healthcare Services

Digital Biology Market Outlook Through 2030: Growth Trends

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Digital Biology Market From 2026 To 2030?

The digital biology market has experienced significant expansion in recent years. Projections indicate its size will increase from $15.97 billion in 2025 to $18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. This historical growth is attributable to factors such as the greater availability of high-throughput biological data, the widening scope of genomic sequencing activities, the surge in bioinformatics research endeavors, the increasing integration of laboratory automation, and advancements in computational processing power.

The digital biology market is projected to experience substantial growth over the coming years, reaching a valuation of $29.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.0%. This expansion during the forecast period is fueled by several factors, including greater funding in AI-powered drug discovery, the proliferation of personalized medicine studies, its expanding application in agricultural and environmental research, the increasing need for scalable cloud-based biological platforms, and enhanced partnerships between technology and life sciences companies.

Key trends anticipated during this forecast period are characterized by the growing uptake of computational biology platforms, a surge in AI-powered biological modeling, enhanced integration of multi-omics data analysis, the proliferation of cloud-based bioinformatics solutions, and a heightened emphasis on digital twin biology.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/digital-biology-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Digital Biology Market?

Increased spending on healthcare research and development is anticipated to fuel the expansion of the digital biology market in the future. Healthcare research and development refers to structured efforts aimed at designing, evaluating, and improving medical treatments, devices, and procedures to enhance health outcomes and patient care. This expenditure is rising due to the growing need for innovative treatments and advanced therapies, prompting companies to invest more in creating new drugs, medical devices, and personalized medicine solutions that address complex and emerging health challenges. Healthcare research and development funding supports digital biology by financing the creation of sophisticated computational tools and bioinformatics platforms, which enable faster analysis of biological data and more accurate disease modeling to improve diagnostics and treatments. For instance, in June 2025, the Department for Science, Innovation and Technology, a UK-based government ministry, announced a $114.38 billion (£86 billion) investment over four years to support science and technology research and development, including drug development, with annual spending of $29.93 billion (£22.5 billion). Consequently, the surge in healthcare research and development expenditure is driving the growth of the digital biology market.

How Is Segmentation Applied In The Digital Biology Market Segment Analysis?

The digital biology market covered in this report is segmented –

1) By Component: Software, Hardware, Services

2) By Deployment Mode: On Premises, Cloud

3) By Technology: Artificial Intelligence In Biology, Bioinformatics Tools And Software, Blockchain For Data Integrity, Cloud Computing Solutions, Deoxyribonucleic Acid Data Storage Technology

4) By Application: Drug Discovery, Agriculture, Environmental Monitoring, Personalized Medicine, Synthetic Biology, Bioinformatics, Other Applications

5) By End User: Pharmaceutical and Biotechnology Companies, Research and Academic Institutes, Healthcare Providers, Contract Research Organizations, Government and Regulatory Bodies

Subsegments:

1) By Software: Genomic Data Analysis, Proteomics Analysis, Metabolomics Analysis, Transcriptomics Analysis, Clinical Bioinformatics, Data Visualization Tools, Laboratory Information Management Systems

2) By Hardware: Sequencing Instruments, Mass Spectrometry Systems, Microscopy Instruments, Chromatography Equipment, Cell Culture Instruments, Laboratory Automation Equipment

3) By Services: Bioinformatics Consulting, Data Management Services, Genetic Testing Services, Clinical Trial Support Services, Custom Assay Development, Laboratory Management Services, Training And Support Services

Which Trends Are Shaping The Digital Biology Market?

Leading companies in the digital biology market are increasingly adopting artificial intelligence for the purpose of drug discovery and predictive biology. Artificial intelligence allows for quicker identification of therapeutic targets, optimizes the development of drugs, and supports the creation of precise, patient-specific treatments. For instance, in December 2024, GenBio AI, a US-based digital biology company, launched Phase 1 of the AI-Driven Digital Organism (AIDO). This innovative platform enables comprehensive modeling of DNA (deoxyribonucleic acid), RNA (ribonucleic acid), protein, and single-cell expression, furnishing researchers with advanced tools to simulate biological systems and accelerate medical research, drug discovery, and personalized therapy development.

Who Are The Companies Participating In The Digital Biology Market Environment?

Major companies operating in the digital biology market are Thermo Fisher Scientific, Illumina Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Perkin Elmer, Agilent Technologies Inc., BGI Genomics Co. Ltd., DNAnexus Inc., Seven Bridges Genomics Inc., GenBio Inc., Evogene Ltd., Cradle B.V., Ginkgo Biosecurity, Evolutionary Scale Inc., Naturannova S.A., Nexco Analytics Inc., Latent Labs Inc., BioLizard NV, Lamin Labs Inc., LatchBio Inc., Standard BioTools Inc., Recursion Pharmaceuticals Inc., Insilico Medicine Inc., Deep Genomics Inc., Valo Health Inc., LabGenius Ltd., Arzeda Corp., e-Therapeutics plc, Bio-Map, A-Alpha Bio Inc., Eikon Therapeutics Inc., Proscia Inc., Lifebit Biotech Ltd., Genestack Ltd., Seqera Labs SL, Sciepot, Pluto Biosciences Inc., SciNote LLC, Qlucore AB, 10x Genomics Inc., Bruker Corporation, Bio-Techne Corporation, Resolve Biosciences GmbH, RareCyte Inc., Oxford Nanopore Technologies plc, PacBio, Ultima Genomics Inc., Element Biosciences Inc., Benchling Inc., and Synthace Ltd.

Get The Full Digital Biology Market Report:

https://www.thebusinessresearchcompany.com/report/digital-biology-global-market-report

Which Region Leads The Digital Biology Market In Terms Of Market Share?

North America was the largest region in the digital biology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Digital Biology Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/digital-biology-global-market-report

Browse Through More Reports Similar to the Global Digital Biology Market 2026, By The Business Research Company

Digital Genome Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-genome-global-market-report

Computational Biology Market Report 2026

https://www.thebusinessresearchcompany.com/report/computational-biology-global-market-report

Digital Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795